Building Blocks

<p>2-[(Thiophen-2-yl)carbonyl]pyridine is a diastereoselective, enantiopure, and ligand-free asymmetric synthesis of pyridines from the reaction of amines with anions. The reaction is catalyzed by a chiral tetrafluoroborate salt and proceeds with high yields and diastereoselectivities. This process can be used to synthesize pyridines from anion precursors that are not commercially available or are too expensive for large scale production. 2-[(Thiophen-2-yl)carbonyl]pyridine has been shown to have optical resolution in both the (+) and (-) configurations, which makes it ideal for use in pharmaceuticals or other biological applications.</p>

<p>4-Methylcyclohexaneacetic acid, mixture of cis and trans is a white crystalline solid with a melting point of about 125°C. It is soluble in organic solvents, including diethanolamine, ethanolamine, and amines. 4-Methylcyclohexaneacetic acid is commercially available as the mixture of cis and trans isomers. This compound has been used to synthesize ferroelectric materials because it can be readily polymerized with ethylene glycol or diethylether. 4-Methylcyclohexaneacetic acid has also been used as an intermediate for the manufacture of pharmaceuticals.</p>

<p>Versatile small molecule scaffold</p>

<p>4-Butyl-3-thiosemicarbazide is an intermediate used to synthesize thiosemicarbazide, which is a type of insecticide. The compound has shown insecticidal properties in the form of a cycloalkenyl or alkenyl group. 4-Butyl-3-thiosemicarbazide can be used as an intermediate for the synthesis of other compounds. It has also been shown to have antiinflammatory properties by inhibiting prostaglandin synthesis.</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>N-(Propan-2-yl)benzenecarbonimidoyl chloride (PCI) is a synthetic, water-soluble drug that is used to treat anaerobic infections. PCI binds to the imidoyl group of bacterial enzymes, such as penicillinase and beta-lactamase, and inhibits their activity. It has been shown that PCI has an affinity for copper ions in the crystallographic analysis. This affinity can be optimized by changing the substituents on the phenyl ring to increase affinity for copper ions. The oxadiazoles and hydroxyalkyl groups are also being considered for optimization of this compound. PCI has been shown to inhibit the growth of various bacteria in screening tests with a shift in its absorption spectrum.</p>

Versatile small molecule scaffold

<p>N1-[4-(Allyloxy)phenyl]acetamide is a catalyst which is used to synthesize polyolefins, such as polyethylene and polypropylene. It has been shown to be an effective catalyst for the polymerization of ethylene. N1-[4-(Allyloxy)phenyl]acetamide has also been shown to have a high activity in the synthesis of polyolefins, with rates comparable to those of the most commonly used catalysts. The crystal structure of this compound was determined by X-ray diffraction analysis and found to contain two crystallographic asymmetric units. This complex can be immobilized on titanium or zirconium oxide supports and is soluble in dichloromethane. The molecular structure of N1-[4-(Allyloxy)phenyl]acetamide has been analyzed by X-ray crystallography and found to contain a planar acetamide group that is connected through a methylene bridge with an allyl</p>

<p>2-(1-Phenyl-ethylamino)-ethanol is an organic compound that is used as a catalyst. The compound is produced industrially by the reaction of formaldehyde with phenethylamine, followed by hydrogenation and hydrolysis. 2-(1-Phenyl-ethylamino)-ethanol can be used as a catalyst in the synthesis of oxazolidines, ketones, and other compounds containing aldehydes or carboxylic acids. It also has basic properties, which means it will react with acidic compounds to produce salts. 2-(1-Phenyl-ethylamino)-ethanol binds to amino alcohols and pyrroles through hydrogen bonding interactions.</p>

<p>Propanebis(imidamide) dihydrochloride is a drug that inhibits the enzyme guanylate cyclase. It is used to treat cardiovascular disorders, such as angina pectoris and hypertension. Propanebis(imidamide) dihydrochloride has been shown to inhibit the kinase, cyclase, and phosphodiesterase enzymes. This inhibition leads to an increase in the levels of cyclic guanosine monophosphate (cGMP). As a result, blood vessels are dilated, which reduces blood pressure and heart rate. The drug also increases the levels of intracellular cGMP by inhibiting protein kinase G. Propanebis(imidamide) dihydrochloride can be administered orally or intravenously.</p>

<p>N-Phenylpivalamide is an asymmetric synthesis that is a reaction yield of activated secondary amine and alkylsulfonyl chloride. The effective dose of n-phenylpivalamide is 0.01 mg/kg and the chloride ion, nitrogen atoms, and amines are all reactive functional groups. The nmr spectra show that this compound has stereoisomers.</p>

<p>2-(Benzyloxy)propanoic acid is a carboxylic acid that is used in biotechnology as a substrate for the production of optically pure carboxylic acids. It can be converted to pure hydroxyapatite, which is an important component of bone grafts and dentures. The microbial synthesis of 2-(benzyloxy)propanoic acid has been studied extensively. The n-terminal amino group can be removed by reduction with sodium sulfate or sodium borohydride, and the resulting alcohols can be converted to esters either enzymatically or with organic acids. 2-(Benzyloxy)propanoic acid also reacts with dodecyl mercaptan to give the corresponding dodecyl sulfate.</p>

<p>5-Chloro-N-(2-chlorophenyl)-2-hydroxybenzamide is a promyelocytic leukemia (PML) inhibitor that has been shown to have significant cytotoxicity against leukemia cells. 5-Chloro-N-(2-chlorophenyl)-2-hydroxybenzamide also inhibits the growth of prostate cancer cells and cervical cancer cells. It has been shown to inhibit the expression of oncogenes, such as sarcoma viral oncogene (SV40), and induce apoptosis in human cancer cells. This drug also shows significant cytotoxicity against human leukemia HL60 cells and erythroleukemia U937 cells.</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>